Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Page 1
Cost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan.
Kobayashi J, Baron SJ, Takagi K, Thompson CA, Jiao X, Yamabe K. Kobayashi J, et al. Among authors: thompson ca. J Med Econ. 2024 Jan-Dec;27(1):697-707. doi: 10.1080/13696998.2024.2346397. Epub 2024 May 6. J Med Econ. 2024. PMID: 38654415 Free article. Updated.
Scenario analyses were performed to determine the impact of lower mean age (77.5 years) and the effect of two different long-term mortality hazard ratios (TAVI versus SAVR: 0.9-1.09) on both risk-level populations. ...
Scenario analyses were performed to determine the impact of lower mean age (77.5 years) and the effect of two different long-term mor …
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
Cerhan JR, Maurer MJ, Link BK, Feldman AL, Habermann TM, Jaye DL, Burack WR, McDonnell TJ, Vega F, Chapman JR, Syrbu S, Vij KR, Inghirami G, Leonard JP, Bernal-Mizrachi L, Farooq U, Witzig TE, Weiner GJ, Wang Y, Alderuccio JP, Slager SL, Larson MC, Riska SM, Gysbers BJ, Lunde JJ, Reicks TW, Ayers AA, O'Leary CB, Yost KJ, Liu H, Nowakowski GS, Ruan J, Chihara D, Koff JL, Casulo C, Thompson CA, Cohen JB, Kahl BS, Nastoupil LJ, Lossos IS, Friedberg JW, Martin P, Flowers CR. Cerhan JR, et al. Among authors: thompson ca. Am J Hematol. 2024 Mar;99(3):408-421. doi: 10.1002/ajh.27202. Epub 2024 Jan 13. Am J Hematol. 2024. PMID: 38217361
To address the current and long-term unmet health needs of the growing population of non-Hodgkin lymphoma (NHL) patients, we established the Lymphoma Epidemiology of Outcomes (LEO) cohort study (NCT02736357; https://leocohort.org/). ...
To address the current and long-term unmet health needs of the growing population of non-Hodgkin lymphoma (NHL) patients, we establis …
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
Larsen CM, Garcia Arango M, Dasari H, Arciniegas Calle M, Adjei E, Rico Mesa J, Scott CG, Thompson CA, Cerhan JR, Haddad TC, Goetz MP, Herrmann J, Villarraga HR. Larsen CM, et al. Among authors: thompson ca. JAMA Netw Open. 2023 Feb 1;6(2):e2254669. doi: 10.1001/jamanetworkopen.2022.54669. JAMA Netw Open. 2023. PMID: 36735254 Free PMC article.
IMPORTANCE: Anthracyclines increase the risk for congestive heart failure (CHF); however, long-term cumulative incidence and risk factors for CHF after anthracycline therapy are not well defined in population-based studies. OBJECTIVE: To compare the long-term cumula …
IMPORTANCE: Anthracyclines increase the risk for congestive heart failure (CHF); however, long-term cumulative incidence and risk fac …
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
This extension study recruited from NAVIGATOR and SOURCE and aimed to evaluate the long-term safety and efficacy of tezepelumab in individuals with severe, uncontrolled asthma. ...These findings are consistent with previous randomised, placebo-controlled studies and show t …
This extension study recruited from NAVIGATOR and SOURCE and aimed to evaluate the long-term safety and efficacy of tezepelumab in in …
Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient population.
Sevilla JP, Klusty JM, Song Y, Russo MJ, Thompson CA, Jiao X, Clancy SJ, Bloom DE. Sevilla JP, et al. Among authors: thompson ca. J Med Econ. 2022 Jan-Dec;25(1):1051-1060. doi: 10.1080/13696998.2022.2112442. J Med Econ. 2022. PMID: 35983718 Free article.
LIMITATIONS: Among study limitations were scarcity of evidence regarding key parameters and the lack of long-term survival, health utility, and treatment cost data. Our analysis did not account for TAVR durability, retreatments, and valve-in-valve treatments. ...
LIMITATIONS: Among study limitations were scarcity of evidence regarding key parameters and the lack of long-term survival, health ut …
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis.
Strouse CS, Larson MC, Ehlers SL, Yost KJ, Maurer MJ, Ansell SM, Inwards DJ, Johnston PB, Micallef IN, Link BK, Farooq U, Cerhan JR, Thompson CA. Strouse CS, et al. Among authors: thompson ca. JCO Oncol Pract. 2022 Jul;18(7):e1069-e1080. doi: 10.1200/OP.21.00694. Epub 2022 May 20. JCO Oncol Pract. 2022. PMID: 35594505 Free PMC article.
PURPOSE: This study assessed the long-term quality of life (QOL) of patients with aggressive lymphoma subtypes treated with autologous hematopoietic cell transplant (autoHCT) compared with those without history of transplant. ...
PURPOSE: This study assessed the long-term quality of life (QOL) of patients with aggressive lymphoma subtypes treated with autologou …
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.
Boddicker NJ, Larson MC, Castellino A, Herrmann J, Inwards DJ, Thanarajasingam G, Maurer MJ, Allmer C, Witzig TE, Nowakowski GS, Habermann TM, Villarraga HR, Slager SL, Cerhan JR, Thompson CA. Boddicker NJ, et al. Among authors: thompson ca. Am J Hematol. 2021 Aug 1;96(8):979-988. doi: 10.1002/ajh.26230. Epub 2021 May 27. Am J Hematol. 2021. PMID: 33971040 Free PMC article.
The development of cardiovascular disease (CVD) in long-term survivors of lymphoma is of increasing importance. Here, we characterize the cumulative incidence and risk factors for CVD in lymphoma patients diagnosed in the current treatment era. ...
The development of cardiovascular disease (CVD) in long-term survivors of lymphoma is of increasing importance. Here, we characterize …
Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivo.
Hiller BM, Marmion DJ, Gross RM, Thompson CA, Chavez CA, Brundin P, Wakeman DR, McMahon CW, Kordower JH. Hiller BM, et al. Among authors: thompson ca. Stem Cells Transl Med. 2021 Feb;10(2):278-290. doi: 10.1002/sctm.20-0014. Epub 2020 Sep 30. Stem Cells Transl Med. 2021. PMID: 32997443 Free PMC article.
We transplanted the cells to athymic rats with unilateral 6-hydroxydopamine lesions and monitored long-term survival and function of the grafts. Transplants of cells manufactured using MMC had low proliferation while still permitting robust survival and function comparable …
We transplanted the cells to athymic rats with unilateral 6-hydroxydopamine lesions and monitored long-term survival and function of …
41 results